Clinical Practice Guidelines for delivery of healthcare to patients with Pompe disease

.

Bibliographic Details
Published in:	Нервно-мышечные болезни
Main Authors:	S. S. Nikitin, S. I. Kutsev, E. N. Basargina, S. V. Mikhaylova, E. Yu. Zakharova, V. I. Larionova, S. I. Polyakova, N. P. Kotlukova, E. N. Arkhipova, M. O. Kovalchuk, N. V. Buchinskaya
Format:	Article
Language:	Russian
Published:	ABV-press 2016-03-01
Online Access:	https://nmb.abvpress.ru/jour/article/view/136

Similar Items

ALGLUCOSIDASE ALFA — A NEW STAGE IN THE THERAPY OF INFANTILE POMPE DISEASE
by: E. N. Basargina, et al.
Published: (2014-09-01)

Infantile Pompe disease: Clinical picture, diagnosis, and treatment
by: N. P. Kotlukova, et al.
Published: (2015-02-01)

Use of Implantable Venous Port Systems in the Treatment of Children with Orphan Diseases (Mucopolysaccharidosis and Pompe Disease): Case Series
by: M. Yu. Rykov, et al.
Published: (2015-09-01)

Late-onset Pompe disease: first clinical description in Russia
by: S. S. Nikitin, et al.
Published: (2015-02-01)

Late-onset Pompe disease with phenotype of the limb-girdle muscular dystrophy
by: S. A. Kurbatov, et al.
Published: (2015-09-01)

Infantile-onset Pompe disease (the first case diagnosed in Voronezh)
by: V. P. Fedotov, et al.
Published: (2015-02-01)

Laboratory studies and Pompe disease: from suspicion to therapy monitoring
by: K. V. Savost’yanov, et al.
Published: (2016-03-01)

THE ANALYSIS OF THE PHARMACEUTICAL MARKET ON THE EXAMPLE OF MEDICINES OF GROUP OF INHIBITORS OF THE PROTON POMP
by: N. V. Mazova, et al.
Published: (2019-01-01)

N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN DIAGNOSTICS OF NON-COMPACTED MYOCARDIUM IN CHILDREN
by: E. N. Arkhipova, et al.
Published: (2012-10-01)

Late-onset Pompe disease: preliminary results of enzyme replacement therapy
by: L. P. Smertina, et al.
Published: (2019-07-01)

HEALTHCARE DELIVERY
by: G Solanki, et al.
Published: (2022-07-01)

Relationship between the cytokine profile of supernatants of invasive breast carcinoma and its molecular and histopathological characteristics
by: A. I. Autenshlyus, et al.
Published: (2024-01-01)

A case of Pompe disease in infant
by: E. F. Sudorgina, et al.
Published: (2015-02-01)

MAGNETIC RESONANCE IMAGING IN DIAGNOSING FIBROTIC AND CICATRICIAL HEART ALTERATIONS IN CHILDREN
by: L. S. Namazova-Baranova, et al.
Published: (2014-03-01)

New АСС/AHA and ESC/ESH arterial hypertension guidelines
by: E. V. Reznik, et al.
Published: (2018-10-01)

CLINICAL GUIDELINES FOR FAMILIAL HYPERCHOLESTEROLEMIA
by: M. V. Ezhov, et al.
Published: (2019-03-01)

The place of ramipril in modern guidelines for the management of patients with cardiovascular diseases
by: E. E. Averin, et al.
Published: (2019-01-01)

How to Distinguish Attenuated Forms of Mucopolysaccharidosis and Articular Forms of Juvenile Arthritis: Development of Diagnostic Algorithm Based on the Data from Multicenter Retrospective Study
by: Natalia V. Buchinskaya, et al.
Published: (2023-01-01)

Guidelines for the diagnosis, treatment and clinical monitoring of patients with juvenile and adult Pompe disease
by: Juan Clinton Llerena Junior, et al.
Published: (2015-01-01)

Clinical examination of patients with late-onset Pompe disease: typical and not typical symptoms and signs
by: S. S. Nikitin
Published: (2020-01-01)

Prevalence of acromegaly and clinical guidelines
by: V. S. Pronin, et al.
Published: (2014-12-01)

WHAT PEDIATRICIANS SHOULD KNOW ABOUT INFANTILE HEMANGIOMAS
by: I. N. Zakharova, et al.
Published: (2016-12-01)

Social-economic burden of Pompe disease with late onset in the Russian Federation
by: A. S. Kolbin, et al.
Published: (2019-04-01)

Characteristics of Pompe disease in China: a report from the Pompe registry
by: Yuying Zhao, et al.
Published: (2019-04-01)

Clinical-economic evaluation of a screening for Pompe disease in children in the local conditions
by: A. S. Kolbin, et al.
Published: (2021-02-01)

NOONAN SYNDROME AS RESULT OF MUTATION p. S257L OF GENE RAF1: CLINICAL CASE AND REVIEW
by: A. A. Bukaeva, et al.
Published: (2016-10-01)

Late-Onset Pompe Disease with Nemaline Bodies
by: E. Frezza, et al.
Published: (2018-01-01)

CURRENT GUIDELINES FOR DIAGNOSIS AND TREATMENT OF VEGETATIVE DYSTONIA IN CHILDREN AND ADOLESCENTS
by: I. N. Zakharova, et al.
Published: (2016-12-01)

COMORBIDITIES IN PRACTICE. CLINICAL GUIDELINES
by: R. G. Oganov, et al.
Published: (2017-12-01)

Epithelial – mesenchymal transition markers, proliferation markers, and cytokine secretion in breast tissue in malignant and benign breast diseases
by: A. I. Autenshlyus, et al.
Published: (2024-01-01)

The optimal time for hematopoietic stem cell translantation for Hodgkin's lymphoma. International guidelines and real practic in Russia and former USSSR countries (Part II)
by: N. V. Zhukov, et al.
Published: (2015-01-01)

The optimal time for hematopoietic stem cell translantation for Hodgkin's lymphoma. International guidelines and real practic in Russia and former USSSR countries (Part II)
by: N. V. Zhukov, et al.
Published: (2015-01-01)

Rationale for implementation study to introduce clinical guidelines on lipid metabolism disorders into routine practice
by: E. I. Usova, et al.
Published: (2023-12-01)

Muscle biopsy in Pompe disease Biópsia muscular na doença de Pompe
by: Lineu Cesar Werneck, et al.
Published: (2013-05-01)

Russian clinical practice guidelines «congenital adrenal hyperplasia»
by: N. G. Mokrysheva, et al.
Published: (2021-10-01)

2020 Clinical practice guidelines for Myocarditis in adults
by: G. P. Arutyunov, et al.
Published: (2021-12-01)

Management of a Pregnancy Complicated by Pompe Disease
by: Jennifer Weida, et al.
Published: (2012-01-01)

Review of the international consensus guidelines for the optimal use of the polymyxins
by: Eliseeva E.V., et al.
Published: (2019-12-01)

COVID-19 vaccination guidelines for patients with multiple sclerosis
by: N. V. Khachanova, et al.
Published: (2021-04-01)

Doctors’ Adherence to the Guidelines on the Oral Anticoagulants Usage
by: N. B. Perepech, et al.
Published: (2020-11-01)